A Commentary on Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families

Journal of Human Genetics

Volumn 58, Issue 2, 2013, Pages 58-

  Kiyotani, Kazuma ^a   Katagiri, Toyomasa ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; RAD51 PROTEIN;

ALLELE; BREAST CANCER; BRIP2 GENE; CANADA; CANCER FAMILY; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; DNA DAMAGE; FAMILIAL CANCER; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; NOTE; PALB2 GENE; PROMOTER REGION; RISK FACTOR; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; ZBRK1 GENE; ZNF350 GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS;

EID: 84875435594     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2012.142     Document Type: Note

References (9)

1. Stratton, M. R. & Rahman, N. The emerging landscape of breast cancer susceptibility. Nat. Genet. 40, 17-22 (2008).
2. Meindl, A., Ditsch, N., Kast, K., Rhiem, K. & Schmutzler, R. K. Hereditary breast and ovarian cancer: new genes, new treatments, new concepts. Dtsch. Arztebl. Int. 108, 323-330 (2011).
3. Zheng, L., Pan, H., Li, S., Flesken-Nikitin, A., Chen, P. L., Boyer, T. G. et al. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol. Cell 6, 757-768 (2000).
4. Plourde, K. V., Labrie, Y., Desjardins, S., Belleau, P., Ouellette, G., Durocher, F. et al. Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families. J. Hum. Genet. 58, 59-66 (2013).
5. Desjardins, S., Belleau, P., Labrie, Y., Ouellette, G., Bessette, P., Chiquette, J. et al. Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families. Int. J. Cancer 122, 108-116 (2008).
6. Huo, X., Lu, C., Huang, X., Hu, Z., Jin, G., Ma, H. et al. Polymorphisms in BRCA1, BRCA1-interacting genes and susceptibility of breast cancer in Chinese women. J. Cancer Res. Clin. Oncol. 135, 1569-1575 (2009).
7. Rutter, J. L., Smith, A. M., Dávila, M. R., Sigurdson, A. J., Giusti, R. M., Pineda, M. A. et al. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. Hum. Mutat. 22, 121-128 (2003).
8. Yarden, R. I., Friedman, E., Metsuyanim, S., Olender, T., Ben-Asher, E. & Papa, M. Z. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Mol. Carcinog 49, 545-555 (2009).
9. Garćia-Closas, M., Egan, K. M., Newcomb, P. A., Brinton, L. A., Titus-Ernstoff, L., Chanock, S. et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum. Genet. 119, 376-388 (2006).